Federal
Register Notices > Notices
of Application - 2004 > Mallinckrodt Inc.
FR Doc 04-5773
[Federal Register: March 15, 2004 (Volume 69, Number 50)]
[Notices]
[Page 12179]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15mr04-107]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice
of Application
Pursuant to Sec.
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR),
this is notice that on January 5, 2004, Mallinckrodt Inc., Mallinckrodt
& Second Streets, St. Louis, Missouri 63147, made application by
renewal to the Drug Enforcement Administration (DEA) for registration as
a bulk manufacturer of the basic classes of controlled substances listed
below.
Drug |
Schedule |
Tetrahydrocannabinols (7370) |
I |
Codeine-N-oxide (9053) |
I |
Dihydromorphine (9145) |
I |
Difenoxin (9168) |
I |
Heroin (9200) |
I |
Morphine-N-oxide (9307) |
I |
Nicomorphine (9312) |
I |
Normorphine (9313) |
I |
Norlevorphanol (9634) |
I |
Amphetamine (1100) |
II |
Methamphetamine (1105) |
II |
Methylphenidate (1724) |
II |
Codeine (9050) |
II |
Diprenorphine (9058) |
II |
Etorphine HCL (9059) |
II |
Dihydrocodeine (9120) |
II |
Hydromorphone (9150) |
II |
Oxycodone (9143) |
II |
Diphenoxylate (9170) |
II |
Benzoylecgonine (9180) |
II |
Hydrocodone (9193) |
II |
Levorphanol (9220) |
II |
Meperidine (9230) |
II |
Methadone (9250) |
II |
Methadone Intermediate (9254) |
II |
Metopon (9260) |
II |
Dextropropoxyphene (9273) |
II |
Morphine (9300) |
II |
Thebaine (9333) |
II |
Opium extracts (9610) |
II |
Opium fluid extract (9620) |
II |
Opium tincture (9630) |
II |
Opium, powdered (9639) |
II |
Opium, granulated (9640) |
II |
Levo-alphacetylmethadol (9648) |
II |
Oxymorphone (9652) |
II |
Alfentanil (9737) |
II |
Sufentanil (9740) |
II |
Fentanyl (9801) |
II |
The firm plans to manufacture the listed
controlled substances for internal use and for sale to other companies.
Any other such applicant and any person who is
presently registered with DEA to manufacture such substance may file
comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed,
in quintuplicate, to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, United States
Department of Justice, Washington, DC 20537, Attention: Federal Register
Representative, Office of Chief Counsel (CCD) and must be filed no later
than May 14, 2004.
Dated: March 5, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 04-5773 Filed 3-12-04; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|